These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9556293)
1. Fetal gender impact on multiple-marker screening results. Bazzett LB; Yaron Y; O'Brien JE; Critchfield G; Kramer RL; Ayoub M; Johnson MP; Evans MI Am J Med Genet; 1998 Apr; 76(5):369-71. PubMed ID: 9556293 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. MacDonald ML; Wagner RM; Slotnick RN Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526 [TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
4. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy. Wenstrom KD; Boots LR; Cosper PC J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763 [TBL] [Abstract][Full Text] [Related]
5. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected? Christiaens GC; Hagenaars AM; Akkerman C; De France HF Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002 [TBL] [Abstract][Full Text] [Related]
6. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
7. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies. Ognibene A; Ciuti R; Tozzi P; Messeri G Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060 [TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Palomaki GE; Knight GJ; Haddow JE; Canick JA; Wald NJ; Kennard A Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315 [TBL] [Abstract][Full Text] [Related]
12. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome. Lehavi O; Aizenstein O; Evans MI; Yaron Y Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504 [TBL] [Abstract][Full Text] [Related]
13. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome]. Liao S; Wang Y; Ye G Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764 [TBL] [Abstract][Full Text] [Related]
17. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus. Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880 [TBL] [Abstract][Full Text] [Related]
18. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
19. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy]. Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094 [TBL] [Abstract][Full Text] [Related]
20. Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers. Bartels I; Bockel B; Caesar J; Krawczak M; Thiele M; Rauskolb R Arch Gynecol Obstet; 1994; 255(2):57-64. PubMed ID: 7522430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]